BlackRock’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-6,303,480
| Closed | -$207M | – | 6043 |
|
|
2022
Q2 | $207M | Sell |
6,303,480
-202,987
| -3% | -$6.42M | 0.01% | 1507 |
|
|
2022
Q1 | $171M | Sell |
6,506,467
-51,670
| -0.8% | -$1.26M | ﹤0.01% | 1777 |
|
|
2021
Q4 | $156M | Buy |
6,558,137
+126,819
| +2% | +$3.13M | ﹤0.01% | 1913 |
|
|
2021
Q3 | $161M | Sell |
6,431,318
-82,582
| -1% | -$2.1M | ﹤0.01% | 1881 |
|
|
2021
Q2 | $169M | Buy |
6,513,900
+23,752
| +0.4% | +$646K | ﹤0.01% | 1896 |
|
|
2021
Q1 | $166M | Buy |
6,490,148
+760,433
| +13% | +$19.5M | ﹤0.01% | 1847 |
|
|
2020
Q4 | $115M | Buy |
5,729,715
+263,371
| +5% | +$5.16M | ﹤0.01% | 2004 |
|
|
2020
Q3 | $93.6M | Sell |
5,466,344
-29,168
| -0.5% | -$551K | ﹤0.01% | 1927 |
|
|
2020
Q2 | $120M | Buy |
5,495,512
+326,103
| +6% | +$7.47M | ﹤0.01% | 1732 |
|
|
2020
Q1 | $120M | Sell |
5,169,409
-204,416
| -4% | -$5.94M | 0.01% | 1530 |
|
|
2019
Q4 | $177M | Buy |
5,373,825
+179,964
| +3% | +$5.77M | 0.01% | 1594 |
|
|
2019
Q3 | $165M | Buy |
5,193,861
+68,609
| +1% | +$2M | 0.01% | 1545 |
|
|
2019
Q2 | $132M | Buy |
5,125,252
+51,849
| +1% | +$1.32M | 0.01% | 1730 |
|
|
2019
Q1 | $129M | Sell |
5,073,403
-117,755
| -2% | -$3.51M | 0.01% | 1712 |
|
|
2018
Q4 | $177M | Buy |
5,191,158
+177,465
| +4% | +$5.77M | 0.01% | 1409 |
|
|
2018
Q3 | $179M | Buy |
5,013,693
+220,521
| +5% | +$7.79M | 0.01% | 1563 |
|
|
2018
Q2 | $165M | Buy |
4,793,172
+466,409
| +11% | +$16.3M | 0.01% | 1600 |
|
|
2018
Q1 | $146M | Buy |
4,326,763
+294,082
| +7% | +$9.31M | 0.01% | 1590 |
|
|
2017
Q4 | $154M | Sell |
4,032,681
-147,440
| -4% | -$5.89M | 0.01% | 1577 |
|
|
2017
Q3 | $157M | Buy |
4,180,121
+30,586
| +0.7% | +$1.08M | 0.01% | 1543 |
|
|
2017
Q2 | $155M | Buy |
4,149,535
+25,340
| +0.6% | +$915K | 0.01% | 1493 |
|
|
2017
Q1 | $162M | Buy |
4,124,195
+4,121,198
| +137,511% | +$155M | 0.01% | 1453 |
|
|
2016
Q4 | $105K | Sell |
2,997
-288
| -9% | -$11.3K | ﹤0.01% | 2515 |
|
|
2016
Q3 | $129K | Buy |
3,285
+189
| +6% | +$7.54K | ﹤0.01% | 2450 |
|
|
2016
Q2 | $117K | Buy |
3,096
+820
| +36% | +$27.5K | ﹤0.01% | 2446 |
|
|
2016
Q1 | $87K | Buy |
2,276
+1,033
| +83% | +$38.5K | ﹤0.01% | 2057 |
|
|
2015
Q4 | $60K | Buy |
1,243
+490
| +65% | +$22.7K | ﹤0.01% | 1962 |
|
|
2015
Q3 | $30K | Sell |
753
-144
| -16% | -$6.12K | ﹤0.01% | 2159 |
|
|
2015
Q2 | $38K | Sell |
897
-38
| -4% | -$1.51K | ﹤0.01% | 2094 |
|
|
2015
Q1 | $37K | Sell |
935
-189
| -17% | -$6.97K | ﹤0.01% | 2082 |
|
|
2014
Q4 | $41K | Hold |
1,124
| – | – | ﹤0.01% | 2042 |
|
|
2014
Q3 | $33K | Hold |
1,124
| – | – | ﹤0.01% | 2115 |
|
|
2014
Q2 | $29K | Sell |
1,124
-61
| -5% | -$1.51K | ﹤0.01% | 2203 |
|
|
2014
Q1 | $31K | Hold |
1,185
| – | – | ﹤0.01% | 2151 |
|
|
2013
Q4 | $27K | Hold |
1,185
| – | – | ﹤0.01% | 2210 |
|
|
2013
Q3 | $16K | Hold |
1,185
| – | – | ﹤0.01% | 2388 |
|
|
2013
Q2 | $16K | Buy |
+1,185
| New | +$16.1K | ﹤0.01% | 2416 |
|
Other funds holding NTUS
BlackRock's NTUS Position: Q3 2022 in Review
BlackRock sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 6,303,480 shares — an estimated $207M sold.
BlackRock first reported a position in NTUS in Q2 2013 and held it in 37 quarters. The position peaked at $207M in Q2 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- BlackRock reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- BlackRock sold 6,303,480 Natus Medical Inc shares in Q3 2022, an estimated $207M.
- BlackRock first reported a position in Natus Medical Inc in Q2 2013 and held it in 37 quarters.
- BlackRock's Natus Medical Inc position peaked at $207M in Q2 2022.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on BlackRock's 13F filing for Q3 2022, filed 14 Nov 2022.